溶酶体功能与胞内位置决定恶性黑色素瘤的恶性表型
研究比较恶性黑色素瘤细胞与正常人黑素细胞的溶酶体功能与空间分布,发现黑色素瘤细胞溶酶体活性增强、分布更分散且外周溶酶体保留蛋白水解活性和低pH。Rab7a表达降低导致溶酶体分散,过表达Rab7a使溶酶体回核周并增加溶酶体自噬、降低迁移能力。研究强调溶酶体改变促进恶性表型,靶向溶酶体功能为未来治疗方向。
要点
- 黑色素瘤细胞溶酶体活性高于正常黑素细胞,且溶酶体分布更分散。
- 黑色素瘤细胞Rab7a表达低于黑素细胞,过表达Rab7a使溶酶体回核周并降低迁移能力。
- 黑色素瘤细胞招募CHMP4B修复溶酶体膜而非启动溶酶体自噬,促核周定位可增加溶酶体自噬。
核心结论
- 溶酶体功能与胞内位置的改变促进恶性黑色素瘤的恶性表型,靶向溶酶体功能可作为未来的治疗方向。
研究设计与样本
- 研究比较恶性黑色素瘤细胞与正常人黑素细胞的溶酶体功能与空间分布,并采用Rab7a过表达和kinesore处理促进核周溶酶体定位。
主要发现
- 黑色素瘤细胞溶酶体活性较正常黑素细胞增强。
- 黑素细胞溶酶体多呈核周分布,黑色素瘤溶酶体更分散,且外周溶酶体群仍保留蛋白水解活性和低pH。
- 黑色素瘤细胞Rab7a表达低于黑素细胞,过表达Rab7a使黑色素瘤溶酶体重新定位至核周区域。
- 溶酶体去稳定药物L-亮氨酰-L-亮氨酸甲酯对黑色素瘤核周溶酶体亚群造成更重损伤,而黑素细胞各亚群易感性无差异。
- 黑色素瘤细胞招募参与溶酶体膜修复的转运必需内体分选复合物-III核心蛋白CHMP4B而非启动溶酶体自噬;Rab7a过表达或kinesore处理促进核周定位时溶酶体自噬增加。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lysosomes are central in cell homeostasis and participate in macromolecular degradation, plasma membrane repair, exosome release, cell adhesion/migration, and apoptosis. In cancer, alterations in lysosomal function and spatial distribution may facilitate disease progression. In this study, we show enhanced lysosomal activity in malignant melanoma cells compared with that in normal human melanocytes. Most lysosomes show perinuclear location in melanocytes, while they are more dispersed in melanoma, with retained proteolytic activity and low pH also in the peripheral population. Rab7a expression is lower in melanoma cells than in melanocytes, and by increasing Rab7a, lysosomes are relocated to the perinuclear region in melanoma. Exposure to the lysosome-destabilizing drug L-leucyl-L-leucine methyl ester causes higher damage in the perinuclear subset of lysosomes in melanomas, whereas differences in subpopulation susceptibility cannot be found in melanocytes. Interestingly, melanoma cells recruit the endosomal sorting complex required for transport-III core protein CHMP4B, involved in lysosomal membrane repair, rather than initiate lysophagy. However, when the perinuclear lysosomal position is promoted by Rab7a overexpression or kinesore treatment, lysophagy is increased. In addition, Rab7a overexpression is accompanied by reduced migration capacity. Taken together, the study emphasizes that alterations in lysosomal properties facilitate the malignant phenotype and declares the targeting of lysosomal function as a future therapeutic approach.
引用
- Eriksson I, Vainikka L, Wäster P, et al. Lysosomal Function and Intracellular Position Determine the Malignant Phenotype in Malignant Melanoma. J Invest Dermatol. 2023. PMID: 36871659. doi:10.1016/j.jid.2023.01.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。